Ev 302 Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ev 302 Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ev 302 Study Today - Breaking & Trending Today

Key Highlights from EV-302 Study at ESMO 2023

Published: December 11, 2023

Expert insight into the data presented at ESMO 2023 on the EV-302 study of enfortumab vedotin and pembrolizumab in the management of locally advanced or metastatic urothelial carcinoma.

Source: ajmc.com

Related Topics:

Sia DaneshmandRadical CystectomyMetastatic DiseaseChemo RadiationPlatinum Based TherapiesEv 302 StudyOpen LabelRandomized StudyEnfortumab Vedotin In CombinationPlatinum Based TherapyStandard Of CareFirst Line Setting